Elements of the endocannabinoid system (ECS) are expressed by islet endocrine cells and activation of CB1 and CB2 cannabinoid receptors regulates insulin secretion from mouse and human β-cells. The current study aimed to investigate the expression and function, in mouse and human β-cells, of monoacylglycerol lipase (MGL), an enzyme that facilitates degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG). We found that MGL mRNA is expressed by MIN6 β-cells, mouse islets, human islets and enriched human islet β-cells, and immunohistochemistry indicated that MGL localisation in human islets is consistent with its expression by some β-and-α-cells. Blockade of MGL activity with the pharmacological inhibitor URB602 led to increased [Ca 2+ ] i and enhanced insulin secretion from MIN6 β-cells, and MGL inhibition also elevated insulin and glucagon secretion from isolated human islets in vitro. These data imply a stimulatory role for endogenous 2-AG in islets that is amplified when its degradation is blocked. © 2012 S. Karger AG, Basel.
CITATION STYLE
Li, C., Vilches-Flores, A., Zhao, M., Amiel, S. A., Jones, P. M., & Persaud, S. J. (2012). Expression and function of monoacylglycerol lipase in mouse β-cells and human islets of langerhans. Cellular Physiology and Biochemistry, 30(2), 347–358. https://doi.org/10.1159/000339069
Mendeley helps you to discover research relevant for your work.